Led by Prof. Stéphanie Allassonnière, this panel unites leaders from AWS, Bristol Myers Squibb, Bioptimus, and the NHS to explore how AI agents are redefining patient care. The conversation highlights specific breakthroughs, such as accelerating early diagnosis in rare diseases and utilizing biological foundation models to enhance clinical research. Beyond the technology, experts discuss the operational realities of deploying these agents, focusing on reducing clinician workload and establishing new governance frameworks for risk management. Ultimately, the session underscores the cross-industry collaboration required to safely scale agentic AI for better patient outcomes and hospital efficiency.
